XGN Competitors & Alternatives
Compare Exagen Inc with similar stocks in the same industry
Diagnostics & Research
XGN
Main Stock$4.54
Tradestie Score
49
Market Cap
$241.60M
Revenue Growth
0.1%
Analyst Upside
+90.9%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NEO
NeoGenomics, Inc.
|
$11.13
|
$1.13B | - | 55 | Compare |
|
CDNA
CareDx, Inc.
|
$26.18
|
$798.40M | - | 66 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$18.00
|
$719.31M | - | 47 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$21.12
|
$667.77M | - | 52 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$10.54
|
$612.76M | - | 54 | Compare |
|
FULC
Fulcrum Therapeutics, Inc. Common Stock
|
$3.70
|
$504.67M | - | 58 | Compare |
|
APYX
Apyx Medical Corporation Common Stock
|
$4.11
|
$81.31M | - | 54 | Compare |
|
BDSX
Biodesix, Inc. Common Stock
|
$16.81
|
$61.36M | - | 57 | Compare |
|
TELA
TELA Bio, Inc. Common Stock
|
$0.80
|
$59.42M | - | 52 | Compare |
|
VRCA
Verrica Pharmaceuticals Inc. Common Stock
|
$5.63
|
$41.94M | - | 49 | Compare |
More XGN Analysis
Data updated: Jun 18, 2026 | Industry: Diagnostics & Research (SIC 8071)
39 stocks in this industry